Maximising clinical trial participation - how important is the social context?

Reaney, Matthew D., Speight, Jane and Martin, Colin 2008, Maximising clinical trial participation - how important is the social context?, in ISPOR 2008 : Moving and Improving Concepts & Evidence for Health Care Decisions : 11th Annual European Congress, International Society for Pharmacoeconomics and Outcomes Research,.


Title Maximising clinical trial participation - how important is the social context?
Author(s) Reaney, Matthew D.
Speight, Jane
Martin, Colin
Conference name Annual European Congress (11th : 2008 : Athens, Greece)
Conference location Athens, Greece
Conference dates 8-11 Nov. 2008
Title of proceedings ISPOR 2008 : Moving and Improving Concepts & Evidence for Health Care Decisions : 11th Annual European Congress
Editor(s) [Unknown]
Publication date 2008
Publisher International Society for Pharmacoeconomics and Outcomes Research
Summary Individuals participate in clinical research for a variety of reasons, dependant not only on the trial phase and their own clinical status but also their sense of optimism, altruism, clinician influence, or financial gain. Practical factors influencing participation may include geographical access, motivation, availability, and language spoken. Widely-used health psychology models (e.g the Theory of Reasoned Action, the Health Belief Model) demonstrate that, in addition to these factors, the primary reason for non-participation in clinical research is social perception of risk. These models detail how beliefs and attitudes toward clinical research develop within, and are influenced by, an individual's social context. Perceived social benefits and barriers toward participation are considered alongside perceived susceptibility and severity of side-effects from participation, or symptoms of disease. A major factor in such models is the subjective norm i.e. individuals' beliefs that important others expect or wish him/her to perform this behaviour, and the motivation to act in accordance with their expectations or wishes. This includes, but is not limited to, the role of the media, peers and family members, clarification of risk associated with trial participation and discussion of comparative risk, and risk equivalence between trials and same treatment outside trials.
The workshop will involve a 30 minute presentation from the discussion leaders and a 30 minute group-work session to explore how an understanding of the social context of participation in clinical research can maximise appropriate clinical trial participation.
Language eng
Field of Research 170199 Psychology not elsewhere classified
Socio Economic Objective 970117 Expanding Knowledge in Psychology and Cognitive Sciences
HERDC Research category E2.1 Full written paper - non-refereed / Abstract reviewed
Copyright notice ©2008, ISPOR
Persistent URL http://hdl.handle.net/10536/DRO/DU:30036544

Document type: Conference Paper
Collection: School of Psychology
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Access Statistics: 68 Abstract Views  -  Detailed Statistics
Created: Mon, 15 Aug 2011, 14:27:36 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.